» Articles » PMID: 11925130

Disease Persistence in Patients with Cervical Intraepithelial Neoplasia Undergoing Electrosurgical Conization

Overview
Journal Gynecol Oncol
Date 2002 Apr 2
PMID 11925130
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cone margin status has been reported to be the most important predictor of residual disease in patients with cervical intraepithelial neoplasia (CIN) undergoing electrosurgical excisional treatment. The primary aim of this study of patients treated with electrosurgical conization was to evaluate the association of cone margin status and other clinical and pathologic factors with the probability of residual disease.

Methods: The study population comprised 699 patients with at least one follow-up visit within 12 months of conization. Residual disease was defined as a histology diagnosis of CIN within 3 years of conization. Multivariate associations were evaluated with multiple logistic regression analysis.

Results: Attendance to follow-up was 97% for the second visit and 34% for the third visit. Residual disease was detected in a total of 38 patients (5.4%). The detection rate was 3.3% at the first visit, 2.1% at the second visit, and 0.4% at the third visit. An increased probability of residual disease was associated with a referral Pap smear reported as high-grade squamous intraepithelial neoplasia and carcinoma (odds ratio, 2.9; reference category, low-grade squamous intraepithelial neoplasia). A decreased probability was associated with a squamocolumnar junction entirely visible at the first follow-up visit (odds ratio, 0.2; reference category, squamocolumnar junction not visible). Patient age, time period, lesion size, lesion site, grade of CIN, cone width, cone depth, and margin status had no influence.

Conclusions: The determinants of residual disease in this study differed from those generally reported so far. Factors associated with effectiveness of electrosurgical treatment of CIN need further research.

Citing Articles

Analysis of factors affecting the accuracy of colposcopic diagnosis of cervical lesions: a retrospective cohort study.

Chu Y, Chen Q, Liu R, Zhou X, Bao M, Wang H Front Med (Lausanne). 2024; 11:1462079.

PMID: 39478822 PMC: 11521855. DOI: 10.3389/fmed.2024.1462079.


Relationship between positive margin and residual/recurrence after excision of cervical intraepithelial neoplasia: a systematic review and meta-analysis.

Feng H, Chen H, Huang D, He S, Xue Z, Pan Z Transl Cancer Res. 2022; 11(6):1762-1769.

PMID: 35836541 PMC: 9273651. DOI: 10.21037/tcr-22-1466.


Loop electrosurgical excision procedure combined with cold coagulation for cervical intraepithelial neoplasia and adenocarcinoma in-situ: a feasible treatment with a low risk of residual/recurrent disease.

Yang E, Kim N, Choi J, Kim W, Lee S Infect Agent Cancer. 2020; 15:58.

PMID: 33042214 PMC: 7539458. DOI: 10.1186/s13027-020-00326-3.


Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.

Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P Ecancermedicalscience. 2015; 9:528.

PMID: 25987897 PMC: 4431402. DOI: 10.3332/ecancer.2015.528.


HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice.

Origoni M, Cristoforoni P, Costa S, Mariani L, Scirpa P, Lorincz A Ecancermedicalscience. 2012; 6:258.

PMID: 22778786 PMC: 3388143. DOI: 10.3332/ecancer.2012.258.